Ranbaxy, globally known for its range of anti-infectives and cutting edge medical equipment, is planning to launch over-the-counter products, including Revital multi-vitamin, multi-mineral energiser and digestive pill, Gasdip.
No billings figures were released, however, it is estimated the pharmaceutical industry will spend around US$21 million this year, with Ranbaxy accounting for the biggest piece of the pie.
MindShare managing director, Ashutosh Srivastava, said: "Our better understanding of the OTC market and consumer insights coming out of our proprietary 3D research - a wide-ranging study encompassing social behaviour, attitudes, motivations and beliefs - won us the Ranbaxy agency of record assignment."
Ranbaxy, meanwhile, has added Grey Worldwide to its roster of creative agencies in India.
Ogilvy & Mather, the main agency, will look after the umbrella brand, Ranbaxy Consumer Healthcare.
The appointment of new agencies comes as the pharmaceutical industry is fast diversifying into the health goods category.
